Craf-1 protein kinase is essential for mouse development

Mechanisms of Development

Volumn 76, Issue 1-2, 1998, Pages 141-149

  Wojnowski, Leszek ^a   Stancato, Louis F ^b   Zimmer, Anne M ^a   Hahn, Heidi ^a   Beck, Thomas W ^c   Larner, Andrew C ^b   R Rapp, Ulf ^d   Zimmer, Andreas ^a  

^a NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

^b CENTER FOR BIOLOGICS EVALUATION AND RESEARCH   (United States)

^c SAIC FREDERICK INC   (United States)

^d UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

Cell mutation; Craf 1 protein kinase; Development; Mouse embryo

Indexed keywords

CELL SURFACE RECEPTOR; MUTANT PROTEIN; PROTEIN CRAF 1; PROTEIN KINASE; PROTEIN SERINE THREONINE KINASE; RAF PROTEIN; UNCLASSIFIED DRUG;

ALLELE; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL DIFFERENTIATION; CELL PROLIFERATION; EMBRYO DEATH; GENE MUTATION; GROWTH RETARDATION; LETHALITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ABNORMALITIES, MULTIPLE; ANIMALS; BASE SEQUENCE; CELL DIVISION; FETAL DEATH; FIBROBLASTS; GENE EXPRESSION REGULATION, DEVELOPMENTAL; MICE; MICE, INBRED STRAINS; MICE, MUTANT STRAINS; MOLECULAR SEQUENCE DATA; MUTATION; PROTEINS; SPECIES SPECIFICITY; TNF RECEPTOR-ASSOCIATED FACTOR 3;

ANIMALIA; MAMMALIA; RODENTIA;

EID: 0032143608     PISSN: 09254773     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0925-4773(98)00111-7     Document Type: Article

References (30)

1. Abrams S.I., Hand P.H., Tsang K.Y., Schlom J. Mutant ras epitopes as targets for cancer vaccines. Semin. Oncol. 23:1996;118-134.
2. Brand A.H., Perrimon N. Raf acts downstream of the EGF receptor to determine dorsoventral polarity during Drosophila oogenesis. Genes Dev. 8:1994;629-639.
3. Copp A.J. Death before birth: clues from gene knockouts and mutations. Trends Genet. 11:1995;87-93. [see comments].
4. Daum G., Eisenmann-Tappe I., Fries H.W., Troppmair J., Rapp U.R. The ins and outs of Raf kinases. Trends Biochem. Sci. 19:1994;474-480.
5. Denhardt D.T. Signal-transducing protein phosphorylation cascades mediated by Ras/Rho proteins in the mammalian cell: the potential for multiplex signalling. Biochem. J. 318:1996;729-747.
6. Erhardt P., Troppmair J., Rapp U.R., Cooper G.M. Differential regulation of Raf-1 and B-Raf and Ras-dependent activation of mitogen-activated protein kinase by cyclic AMP in PC12 cells. Mol. Cell. Biol. 15:1995;5524-5530.
7. Henkemeyer M., Rossi D.J., Holmyard D.P., Puri M.C., Mbamalu G., Harpal K., Shih T.S., Jacks T., Pawson T. Vascular system defects and neuronal apoptosis in mice lacking ras GTPase-activating protein. Nature. 377:1995;695-701.
8. Holland, P.W., Garcia-Fernandez, J., Williams, N.A., Sidow, A., 1994. Gene duplications and the origins of vertebrate development. Development (Suppl.), 125-133.
9. Jaiswal R.K., Weissinger E., Kolch W., Landreth G.E. Nerve growth factor-mediated activation of the mitogen-activated protein (MAP) kinase cascade involves a signaling complex containing B-Raf and HSP90. J. Biol. Chem. 271:1996;23626-23629.
10. Johnson L., Greenbaum D., Cichowski K., Mercer K., Murphy E., Schmitt E., Bronson R.T., Umanoff H., Edelmann W., Kucherlapati R., Jacks T. K-ras is an essential gene in the mouse with partial functional overlap with N-ras. Genes Dev. 11:1997;2468-2481.
11. Kaufman, M.H., 1992. The Atlas of Mouse Development. Academic Press, New York.
12. Khosravi-Far R., Der C.J. The Ras signal transduction pathway. Cancer Metastasis Rev. 13:1994;67-89.
13. Kolch W., Heidecker G., Lloyd P., Rapp U.R. Raf-1 protein kinase is required for growth of induced NIH/3T3 cells. Nature. 349:1991;426-428.
14. Luetteke N.C., Qiu T.H., Peiffer R.L., Oliver P., Smithies O., Lee D.C. TGF alpha deficiency results in hair follicle and eye abnormalities in targeted and waved-1 mice. Cell. 73:1993;263-278.
15. MacNicol A.M., Muslin A.J., Williams L.T. Raf-1 kinase is essential for early Xenopus development and mediates the induction of mesoderm by FGF. Cell. 73:1993;571-583.
16. Mansour S.L., Thomas K.R., Capecchi M.R. Disruption of the proto-oncogene int-2 in mouse embryo-derived stem cells: a general strategy for targeting mutations to non-selectable genes. Nature. 336:1988;348-352.
17. Marais R., Light Y., Paterson H.F., Mason C.S., Marshall C.J. Differential regulation of Raf-1, A-Raf, and B-Raf by oncogenic ras and tyrosine kinases. J. Biol. Chem. 272:1997;4378-4383.
18. Mark G.E., Rapp U.R. Primary structure of v-raf: relatedness to the src family of oncogenes. Science. 224:1984;285-289.
19. McLeod M.J. Differential staining of cartilage and bone in whole mouse fetuses by alcian blue and alizarin red S. Teratology. 22:1980;299-301.
20. Nassar N., Horn G., Herrmann C., Scherer A., McCormick F., Wittinghofer A. The 2.2 A crystal structure of the Ras-binding domain of the serine/threonine kinase c-Raf1 in complex with Rap1A and a GTP analogue. Nature. 375:1995;554-560.
21. Pritchard C.A., Bolin L., Slattery R., Murray R., McMahon M. Post-natal lethality and neurological and gastrointestinal defects in mice with targeted disruption of the A-Raf protein kinase gene. Curr. Biol. 6:1996;614-617.
22. Pritchard C.A., Samuels M.L., Bosch E., McMahon M. Conditionally oncogenic forms of the A-Raf and B-Raf protein kinases display different biological and biochemical properties in NIH 3T3 cells. Mol. Cell. Biol. 15:1995;6430-6442.
23. Schwartzberg P.L., Stall A.M., Hardin J.D., Bowdish K.S., Humaran T., Boast S., Harbison M.L., Robertson E.J., Goff S.P. Mice homozygous for the ablm1 mutation show poor viability and depletion of selected B and T cell populations. Cell. 65:1991;1165-1175.
24. Sibilia M., Wagner E.F. Strain-dependent epithelial defects in mice lacking the EGF receptor. Science. 269:1995;234-238. (published erratum appears in Science, 269 (1995) 909).
25. Stancato L.F., Sakatsume M., David M., Dent P., Dong F., Petricoin E.F., Krolewski J.J., Silvennoinen O., Saharinen P., Pierce J., Marshall C.J., Sturgill T., Finbloom D.S., Larner A.C. Beta interferon and oncostatin M activate Raf-1 and mitogen-activated protein kinase through a JAK1-dependent pathway. Mol. Cell. Biol. 17:1997;3833-3840.
26. Threadgill D.W., Dlugosz A.A., Hansen L.A., Tennenbaum T., Lichti U., Yee D., LaMantia C., Mourton T., Herrup K., Harris R.C.et al. Targeted disruption of mouse EGF receptor: effect of genetic background on mutant phenotype. Science. 269:1995;230-234.
27. Vassalli A., Matzuk M.M., Gardner H.A., Lee K.F., Jaenisch R. Activin/inhibin beta B subunit gene disruption leads to defects in eyelid development and female reproduction. Genes Dev. 8:1994;414-427.
28. Wojnowski L., Zimmer A.M., Beck T.W., Hahn H., Bernal R., Rapp U.R., Zimmer A. Endothelial apoptosis in Braf-deficient mice. Nature Genet. 16:1997;293-297.
29. Yamauchi N., Kiessling A.A., Cooper G.M. The Ras/Raf signaling pathway is required for progression of mouse embryos through the two-cell stage. Mol. Cell. Biol. 14:1994;6655-6662.
30. Zou X., Rudchenko S., Wong K., Calame K. Induction of c-myc transcription by the v-Abl tyrosine kinase requires Ras, Raf1, and cyclin-dependent kinases. Genes Dev. 11:1997;654-662.